These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35721812)

  • 1. Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis.
    Park JH; Nuñez NA; Gardea-Resendez M; Gerberi DJ; Breitinger S; Veldic M; Frye MA; Singh B
    Psychopharmacol Bull; 2022 May; 52(2):45-72. PubMed ID: 35721812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.
    Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L
    J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.
    Altshuler LL; Sugar CA; McElroy SL; Calimlim B; Gitlin M; Keck PE; Aquino-Elias A; Martens BE; Fischer EG; English TL; Roach J; Suppes T
    Am J Psychiatry; 2017 Mar; 174(3):266-276. PubMed ID: 28135846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.
    Lorenzo-Luaces L; Amsterdam JD
    Psychiatry Res; 2018 Jan; 259():455-459. PubMed ID: 29136600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
    Lorenzo-Luaces L; Amsterdam JD; Soeller I; DeRubeis RJ
    Acta Psychiatr Scand; 2016 Jun; 133(6):459-69. PubMed ID: 26803764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for treatment-resistant depression in adults.
    Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    Br J Psychiatry; 2016 Apr; 208(4):359-65. PubMed ID: 26892848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
    Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
    Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of antidepressant's use in the treatment of depressive episodes in bipolar disorder - review of research.
    Antosik-Wójcińska AZ; Stefanowski B; Święcicki Ł
    Psychiatr Pol; 2015; 49(6):1223-39. PubMed ID: 26909398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis.
    Lindström L; Lindström E; Nilsson M; Höistad M
    J Affect Disord; 2017 Apr; 213():138-150. PubMed ID: 28222360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antidepressants for preventing seasonal affective disorder in adults.
    Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.